Your browser doesn't support javascript.
loading
Multisystem Erdheim-Chester disease presenting with pericardial effusion confirmed by the effusion cytology specimen.
Dai, Shishuo; Su, Xueying; Liu, Wei-Ping; Wu, Yu.
Afiliación
  • Dai S; Department of Clinical Medicine, West China School of Medicine/West China Hospital of Sichuan University, No. 37, Guoxue Lane, Chengdu, Sichuan 610041, China.
  • Su X; Department of Clinical Medicine, West China School of Medicine/West China Hospital of Sichuan University, No. 37, Guoxue Lane, Chengdu, Sichuan 610041, China; Department of Pathology, West China Hospital of Sichuan University, No. 37, Guoxue Lane, Chengdu, Sichuan 610041, China.
  • Liu WP; Department of Clinical Medicine, West China School of Medicine/West China Hospital of Sichuan University, No. 37, Guoxue Lane, Chengdu, Sichuan 610041, China; Department of Pathology, West China Hospital of Sichuan University, No. 37, Guoxue Lane, Chengdu, Sichuan 610041, China.
  • Wu Y; Department of Clinical Medicine, West China School of Medicine/West China Hospital of Sichuan University, No. 37, Guoxue Lane, Chengdu, Sichuan 610041, China; Department of Hematology, West China Hospital of Sichuan University, No. 37, Guoxue Lane, Chengdu, Sichuan 610041, China. Electronic address:
Cardiovasc Pathol ; 70: 107625, 2024.
Article en En | MEDLINE | ID: mdl-38417471
ABSTRACT
Erdheim-Chester disease (ECD) is a rare histiocytosis characterized by the foamy CD68+CD1a- histiocytes infiltrating multiple organs and tissues. ECD might be asymptomatic or present with variable manifestations. The diagnosis of ECD requires characteristic radiological findings and pathological features. Herein, we described a 52-year-old female patient who was admitted to our hospital for recurrent pericardial effusion for two months. She has a medical history of papillary thyroid carcinoma (PTC) and underwent a total thyroidectomy two years before admission. The radiological findings suggested a potential diagnosis of ECD. Cytological analysis of the effusion cytology specimen revealed CD68+CD1a- histiocytes, confirming the ECD diagnosis. The BRAF V600E mutation was identified in the histiocytes, prompting the administration of vemurafenib, a BRAF inhibitor. After two months of standard-dose vemurafenib treatment, the disease was well controlled with pericardial effusion regression.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Asunto principal: Derrame Pericárdico / Enfermedad de Erdheim-Chester / Proteínas Proto-Oncogénicas B-raf / Vemurafenib Límite: Female / Humans / Middle aged Idioma: En Revista: Cardiovasc Pathol / Cardiovasc. pathol / Cardiovascular pathology Asunto de la revista: ANGIOLOGIA / CARDIOLOGIA / PATOLOGIA Año: 2024 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Colección: 01-internacional Asunto principal: Derrame Pericárdico / Enfermedad de Erdheim-Chester / Proteínas Proto-Oncogénicas B-raf / Vemurafenib Límite: Female / Humans / Middle aged Idioma: En Revista: Cardiovasc Pathol / Cardiovasc. pathol / Cardiovascular pathology Asunto de la revista: ANGIOLOGIA / CARDIOLOGIA / PATOLOGIA Año: 2024 Tipo del documento: Article País de afiliación: China